Invitrocue Limited announced the appointment of Chow Yee Koh as an executive director of the Company as replacement of Geoffrey Thomas who is resigning as director of the company to concentrate on his other personal business interests. Mr. Koh has extensive experience in accounting, auditing and corporate finance, accumulated over 20 years from working in audit firms and listed companies. Mr. Koh is also a director of ASX listed Stemcell United Limited. Date of appointment for Chow Yee Koh is March 2, 2020.